Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
British Journal of Cancer|May 9, 2020
Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitorsAmelia McCartney, Luca MalorniAdvances in Experimental Medicine and Biology|January 17, 2025
CDK4/6 Inhibitor Resistance in ER+ Breast CancerIlenia Migliaccio, Cristina Guarducci, Luca MalorniCurrent Opinion in Oncology|September 5, 2014
Cyclin-dependent kinase 4/6 inhibitors in breast cancer therapyIlenia Migliaccio, Angelo Di Leo, Luca MalorniBMC Medicine|April 11, 2015
Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancersIlenia Migliaccio, Luca Malorni, Christopher D Hart, et al.Cancers|December 5, 2019
The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine TherapyIrene De Santo, Amelia McCartney, Ilenia Migliaccio, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer?Mariana Brandão, Rafael Caparica, Luca Malorni, et al.NPJ Breast Cancer|July 20, 2017
A multifactorial 'Consensus Signature' by in silico analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancerNatalie Turner, Mattia Forcato, Simona Nuzzo, et al.Therapeutic Advances in Medical Oncology|December 22, 2018
Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?Lorenzo Rossi, Amelia McCartney, Emanuela Risi, et al.Nature Reviews. Clinical Oncology|May 27, 2015
Challenges in the management of advanced, ER-positive, HER2-negative breast cancerChristopher D Hart, Ilenia Migliaccio, Luca Malorni, et al.Cancers|March 28, 2014
Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Natalie Turner, Marta Pestrin, Francesca Galardi, et al.Pageof 7